Sentences with phrase «new application programming»

The new beta version of the Google app doesn't reveal any specifics regarding the capabilities of Android 8.1 and how the operating system may differ from the previous version, save for the unsurprising fact that it will be accompanied by a new application programming interface level which will replace the API Level 26.

However, Kongregate has plans to use the creatures in some of its future games, as it is developing a new application programming interface (API) for flash game developers to integrate Kongpanions into their games.

Holiday Extras recently started working with Felix Geisendörfer, an expert in the Node.js field, to develop its new Application Programming Interface (API) as part of the company's # 1.5 million investment in hassle - free web technology.

The 3M Cloud Library's powerful new Application Programming Interface (API) suite provides the foundation for the interconnectivity that libraries are seeking.

Clio first opened up the platform in 2012 and in the past year «really doubled down» on its positioning, introducing a new application programming interface (API) that presented additional opportunities for developers.

Not exact matches

In the application, Berkshire said that it did not buy new shares, but hit the threshold due to the buyback program of Wells.

TechStars is loosely affiliated with 30 of these programs -; serving in an advisory capacity and allowing the programs to use its application -; and it runs TechStars programs in New York City, Boston, Seattle, San Antonio, and Boulder.

The Department of Mines and Petroleum has finalised new environmental assessment fees for mining proposals and program - of - work applications, to take effect from July 1.

Google also said that it released several new so - called application program interfaces that give companies the ability to more easily sync data from other companies» services like Salesforce (crm) into Google's own Slides presentation software.

In 1999, IDBs, previously considered an option for only large companies seeking multimillion - dollar loans, got a sleek new look with the creation of the mini-bond program, which offers a streamlined application process, capped fees and quick closings.

When HP tapped L?o Apotheker, the former CEO of SAP, Oracle's archrival in business - application programs, as its new commander - in - chief, Ellison charged HP with «[picking] a guy who was recently fired because he did such a bad job of running SAP,» and called for the board's immediate, «en masse» resignation.

Central to Slack's new initiative is an application programming interface (API) that allows developers to connect the messaging service with their own applications.

That's why in 2012 they launched New York City - based Temboo, a repository of programming processes that developers can use to connect to code utilities, databases and more than 100 application programming interfaces (APIs) for online services ranging from Amazon Web Services cloud storage to real - estate site Zillow.

For example, many content - management systems have add - ons or plug - ins for mobile or social applications, such as a program that allows visitors to use their saved profile to register with your website rather than creating a new one.

The tech titan's BizSpark program, which offered thousands of dollars in free cloud credits, along with free access to Office 365 and Microsoft's Visual Studio developer tools, is no longer accepting new applications, and the company will be eliminating it once the benefits expire for companies already in the program.

Just use a service like Extole to create a referral system built into your application, complete with incentive programs and quality landing pages to drive new customers, all with minimal work on your end.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tprograms; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tPrograms (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tprograms; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

We also are making it easier for partners to modernize existing business applications, and build new ones, with a new program we are calling ISV Cloud Embed.

New program participants will be selected twice a year through an application process, and the qualifying entrepreneurs will receive assistance with the cap - exempt H - 1B visa application process.

With the new funds totaling $ 15 million, Better Mortgage will expand a nascent program of offering homeowners a guaranteed interest rate within 20 minutes of filling out an online application, said Chief Executive Vishal Garg.

Cambridge, MA — February 6, 2017 — Aura Biosciences, a biotechnology company developing a new class of therapies to target and selectively destroy cancer cells using viral nanoparticle conjugates, announced today that the U.S. Food and Drug Administration (FDA) has cleared the investigational new drug application (IND) for the company's lead program, light - activated AU - 011 in ocular melanoma (OM).

Our application is brief, but gives us important insight into your desire to join the program, and what you hope to accomplish with your new skills!

With Canada's Parent and Grandparent sponsorship immigration program (PGP) currently closed for new applications, parents and grandparents who want to join their children and grandchildren in Canada may do so through the Super Visa program, which remains open.

The platform offers a new, extended application programming interface (API) that utilizes a Turing system capable of creating services using cycles, schedules, and unique functions.

For a more specific treatment of preventive programs, see Gerald Caplan, Principles of Preventive Psychiatry (New York: Basic Books, 1964) For the application of these principles of prevention to the role of the clergyman, see J. A. Snyder, «Clergymen and Widening Concepts of Mental Health,» Journal of Religion and Health, July, 1968.

The James Beard Foundation Unveils New JBF National Scholars Program as Part of 2016 Scholarship Opportunities ~ Call for Applications Opens -LSB-...]

ImPACT Applications, Inc., developer of the ImPACT ® test and ImPACT Concussion Management Model, has announced a partnership with New York Schools Insurance Reciprocal (NYSIR), provider of property and casualty insurance programs for New York State public schools and Boards of Cooperative Educational Services (BOCES), to introduce «a comprehensive» Head Injury Prevention Program.

Applications will be reviewed for need, and impact of new equipment on the school foodservice program.

Applications will be reviewed for need, plan to integrate the new equipment, and the impact the equipment will have on the foodservice program.

Assistance offers are made annually and a new application is required each year, as family circumstances and the program's allotment may change.

Coordinate a new national initiative aimed at evaluating youth sports program providers including following - up, tracking and communicating with all applicants to verify application information.

We'll have more on the new program's funding and application process next week.

So it's great news that the U.S. Department of Agriculture has today released a «Request for Applications» (RFA) for a new farm - to - school grant program.

Applications will be reviewed for need, plan to integrate new equipment, and impact of new equipment on your school's foodservice program.

The Senate denies any actions by the Executive to administratively establish an Office of Workforce Development within the Executive Chamber, and any action by the Executive to create a new Consolidated Funding Application through the Regional Economic Development Councils for various existing programs related to workforce development.

The Governor's state of the state message recommended a new, $ 175 million workforce development program that would be implemented through the Consolidated Funding Application (CFA) process, with involvement of the Regional Economic Development Councils (REDC).

New York State has modeled the Certified Application Counselors on successful community assistance programs in New York, as the program is designed for local districts to help meet the needs of county residents by providing assistance in convenient, community - based locations.

U.S. Attorney General Jeff Sessions said Tuesday the administration will stop accepting new applications for President Barack Obama's Deferred Action for Childhood Arrivals program.

U.S. Reps. John Katko (R — Camillus), Claudia Tenney (R — New Hartford), and Elise Stefanik (R — Willsboro) this week urged President Donald Trump, the U.S. Department of Transportation (DOT), and Federal Aviation Administration (FAA) to support New York's application for the FAA unmanned - aircraft systems (UAS) integration pilot program (IPP).

PLATTSBURGH — As details about the state's new free tuition program trickle in, college officials are scrambling to spread the word before the fast - approaching application deadline.

ERIE COUNTY, NY — The Erie County Department of Social Services» Home Energy Assistance Program («HEAP») will continue to accept applications for regular benefits for the 2015 - 2016 heating season after the New York State Office of Temporary Disability Assistance («OTDA») authorized an extension of regular HEAP benefits for New York residents who qualify.

New York State is now accepting applications for its free tuition program.

New York state began accepting applications on Dec. 31 for a new loan forgiveness program that will relieve student debt for recent college graduates living in the state, according to a press release from New York state Gov. Andrew CuoNew York state began accepting applications on Dec. 31 for a new loan forgiveness program that will relieve student debt for recent college graduates living in the state, according to a press release from New York state Gov. Andrew Cuonew loan forgiveness program that will relieve student debt for recent college graduates living in the state, according to a press release from New York state Gov. Andrew CuoNew York state Gov. Andrew Cuomo.

A competition launched by New York state Gov. Andrew Cuomo allowing student groups from colleges and universities in the state to construct plans for clean energy programs has begun accepting applications.

New York is starting to accept applications for testing driverless or automated cars, part of a 12 - month pilot program approved in the state budget.

One company, Far (m) ed New York LLC, announced it was submitting an application to the state Department of Health to become an official provider of medical marijuana under the state's program, which is due to come online in January.

NYC Mayor Bill de Blasio launched the $ 7.9 million ActionNYC program, which will create community hubs across the five boroughs where immigrant New Yorkers can receive information and legal support and get help preparing applications.

«The Department of State already concluded that the Indian Point relicensing application is inconsistent with New York's long - standing Coastal Management Program requirements and will continue to use this program to protect New York's coaProgram requirements and will continue to use this program to protect New York's coaprogram to protect New York's coastline.

ALBANY, N.Y. (AP)-- With New York officials now proposing to spend $ 400 million to buy and demolish downstate homes damaged by October's Superstorm Sandy, they say 646 buyout applications have been federally approved for $ 55 million in a buyout program for upstate properties damaged in 2011 by the back - to - back storms Irene and Lee.

There are more than 340 pending applications for funding through the loan program in New York.